Gil S Leichner - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gil S Leichner

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Angiogenesis|February 5, 2018

Somatic NRAS mutation in patient with generalized lymphatic anomalyEugenia Manevitz-Mendelson, Gil S Leichner, Ortal Barel, et al.

Cancer & Metabolism|May 1, 2025

Proteomic and lipidomic analysis of low-density lipoprotein identifies potential biomarkers of early estrogen receptor-positive breast cancerYamama Abu Mohsen, Rachel Twitto-Greenberg, Anna Cohen, et al.

The Journal of Experimental Medicine|August 21, 2025

A high-throughput zebrafish screen identifies novel candidate treatments for kaposiform lymphangiomatosis (KLA)Ivan Bassi, Amani Jabali, Lotan Levin, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Angiogenesis|February 5, 2018

Somatic NRAS mutation in patient with generalized lymphatic anomalyEugenia Manevitz-Mendelson, Gil S Leichner, Ortal Barel, et al.

Cancer & Metabolism|May 1, 2025

The Journal of Experimental Medicine|August 21, 2025

A high-throughput zebrafish screen identifies novel candidate treatments for kaposiform lymphangiomatosis (KLA)Ivan Bassi, Amani Jabali, Lotan Levin, et al.

Pageof 2